Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma

Published:2014-11-13 Issue:20 Volume:371 Page:1867-1876
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Larkin James,Ascierto Paolo A.,Dréno Brigitte,Atkinson Victoria,Liszkay Gabriella,Maio Michele,Mandalà Mario,Demidov Lev,Stroyakovskiy Daniil,Thomas Luc,de la Cruz-Merino Luis,Dutriaux Caroline,Garbe Claus,Sovak Mika A.,Chang Ilsung,Choong Nicholas,Hack Stephen P.,McArthur Grant A.,Ribas Antoni

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1408868

Cited by 1790 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapy Innovations for Melanoma;Hematology/Oncology Clinics of North America;2024-10

2. MEK inhibitors in oncology: a patent review and update (2016 - present);Expert Opinion on Therapeutic Patents;2024-09-14

3. The impact of statins on melanoma survival: a systematic review and meta-analysis;Melanoma Research;2024-09-12

4. BRAF Inhibition and UVB Light Synergistically Promote Mus musculus Papillomavirus 1-Induced Skin Tumorigenesis;Cancers;2024-09-11

5. Encorafenib plus binimetinib for BRAF V600E-mutant metastatic NSCLC: clinical implications of the phase 2 PHAROS study;Future Oncology;2024-09-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP